Skip to main content

Table 1 Comparison of characteristics of patients between the two groups (TAC versus partial colectomy) before propensity matching

From: Outcomes of total versus partial colectomy in fulminant Clostridium difficile colitis: a propensity matched analysis

Variable

All Patients

N = 491

Total Abdominal Colectomy

N = 398

Partial Colectomy

N = 93

P value

Age (years), Median [Q1-Q3]

67 [57–76]

67 [58–75]

66 [55–75]

0.31

Gender

   

0.22

 Female

263 (53.6)

219 (55)

44 (47.3)

 

 Male

228 (46.4)

179 (45)

49 (52.7)

 

Admitted from

   

0.502

 From acute care hospital inpatient

95 (19.3)

82 (20.6)

13 (14)

 

 Not transferred (admitted from home)

275 (56)

215 (54)

60 (64.5)

 

 Nursing home—Chronic care—Intermediate care

75 (15.3)

61 (15.3)

14 (15.1)

 

 Outside emergency department

38 (7.7)

33 (8.3)

5 (5.4)

 

 Transfer from other

6 (1.2)

5 (1.3)

1 (1.1)

 

 Unknown

2 (0.4)

2 (0.5)

0 (0)

 

Race, white, n (%)

341 (69.5)

269 (67.6)

72 (77.4)

0.084

Sepsis status, n (%)

   

0.031

 None

35 (7.1)

28 (7)

7 (7.5)

 

 Sepsis

111 (22.6)

80 (20.1)

31 (33.3)

 

 Septic Shock

319 (65)

270 (67.8)

49 (52.7)

 

 SIRS

26 (5.3)

20 (5)

6 (6.5)

 

WBC count, 109/L, n (%)

   

 < 0.001

 4–11.9

97 (19.8)

72 (18.1)

25 (26.9)

 

 12–19.9

85 (17.3)

57 (14.4)

28 (30.1)

 

 20–34.9

103 (21)

89 (22.4)

14 (15.1)

 

 35–44.9

56 (11.4)

52 (13.1)

4 (4.3)

 

 ≥ 45

51 (10.4)

41 (10.3)

10 (10.8)

 

 < 4

34 (6.9)

24 (6)

10 (10.8)

 

 Unknown

64 (13.1)

62 (15.6)

2 (2.2)

 

Diabetes, n (%)

   

0.547

 INSULIN

64 (13)

51 (12.8)

13 (14)

 

 NO

387 (78.8)

312 (78.4)

75 (80.6)

 

 NON-INSULIN

40 (8.1)

35 (8.8)

5 (5.4)

 

Smoking, n (%)

   

0.724

 No

379 (77.2)

309 (77.6)

70 (75.3)

 

 Yes

112 (22.8)

89 (22.4)

23 (24.7)

 

Ventilator dependencya, n (%)

   

0.384

 No

327 (66.6)

261 (65.6)

66 (71)

 

 Yes

164 (33.4)

137 (34.4)

27 (29)

 

COPD, n (%)

   

0.387

 No

371 (75.6)

297 (74.6)

74 (79.6)

 

 Yes

120 (24.4)

101 (25.4)

19 (20.4)

 

Ascites, n (%)

   

0.985

 No

430 (87.6)

348 (87.4)

82 (88.2)

 

 Yes

61 (12.4)

50 (12.6)

11 (11.8)

 

CHF, n (%)

   

0.764

 No

442 (90)

357 (89.7)

85 (91.4)

 

 Yes

49 (10)

41 (10.3)

8 (8.6)

 

HTN, n (%)

   

0.721

 No

190 (38.7)

152 (38.2)

38 (40.9)

 

 Yes

301 (61.3)

246 (61.8)

55 (59.1)

 

CRF, n (%)

   

0.226

 No

398 (81.1)

318 (79.9)

80 (86)

 

 Yes

93 (18.9)

80 (20.1)

13 (14)

 

CRF on dialysis, n (%)

   

0.85

 No

422 (85.9)

341 (85.7)

81 (87.1)

 

 Yes

69 (14.1)

57 (14.3)

12 (12.9)

 

Disseminated cancer, n (%)

   

0.002

 No

452 (92.1)

374 (94)

78 (83.9)

 

 Yes

39 (7.9)

24 (6)

15 (16.1)

 

Steroid, n (%)

   

0.047

 No

388 (79)

307 (77.1)

81 (87.1)

 

 Yes

103 (21)

91 (22.9)

12 (12.9)

 

Weight loss

   

0.825

 No

454 (92.5)

367 (92.2)

87 (93.5)

 

 Yes

37 (7.5)

31 (7.8)

6 (6.5)

 

Coagulopathy, n (%)

   

0.57

 No

388 (79)

312 (78.4)

76 (81.7)

 

 Yes

103 (21)

86 (21.6)

17 (18.3)

 

Blood transfusiona, n (%)

   

0.525

 No

437 (89)

352 (88.4)

85 (91.4)

 

 Yes

54 (11)

46 (11.6)

8 (8.6)

 

Wound class, n (%)

   

 < 0.001

 1-Clean

3 (0.6)

1 (0.3)

2 (2.2)

 

 2-Clean/Contaminated

91 (18.5)

82 (20.6)

9 (9.7)

 

 3-Contaminated

166 (33.8)

141 (35.4)

25 (26.9)

 

 4-Dirty/Infected

231 (47)

174 (43.7)

57 (61.3)

 

ASA class, n (%)

   

0.029

 2-Mild Disturb

6 (1.2)

3 (0.8)

3 (3.2)

 

 3-Severe Disturb

75 (15.3)

56 (14.1)

19 (20.4)

 

 4-Life Threat

319 (65)

264 (66.3)

55 (59.1)

 

 5-Moribund

90 (18.3)

75 (18.8)

15 (16.1)

 

 None assigned

1 (0.2)

0 (0)

1 (1.1)

 
  1. ASA; American Society of Anesthesiology, CHF; Congestive heart failure, CRF; chronic renal failure,
  2. COPD; chronic obstructive pulmonary disease, Q1-Q3 ; first quartile-third quartile, interquartile range (IQR), SIRS; systemic inflammatory response syndrome. WBCs; White blood cell counts
  3. aPrior to surgery
  4. n; number of patients, %; percentage